© 2024 New Hampshire Public Radio

Persons with disabilities who need assistance accessing NHPR's FCC public files, please contact us at publicfile@nhpr.org.
Play Live Radio
Next Up:
0:00
0:00
0:00 0:00
Available On Air Stations
Purchase your tickets for a chance to win $35k toward a new car or $25k in cash during NHPR's Summer Raffle!

Personalized Cancer Vaccines Could Be Key Piece Of Cancer 'Moonshot'

A lab technician works at the Center for Genetic Engineering and Biotechnology in Camaguey, Cuba on June 19, 2015. Cuban scientists are working on a vaccine for prostate cancer. (Adalberto Roque/AFP/Getty Images)
A lab technician works at the Center for Genetic Engineering and Biotechnology in Camaguey, Cuba on June 19, 2015. Cuban scientists are working on a vaccine for prostate cancer. (Adalberto Roque/AFP/Getty Images)

In his State of the Union address last night, President Obama said he wants to “make America the country that cures cancer once and for all.”

A key piece of that “moonshot” – as the president and vice president have called it – may be a treatment that’s still very much in the experimental phase: personalized cancer vaccines.

Here & Now’s Jeremy Hobson talks with STAT senior science writer Sharon Begley about how those personalized vaccines – called neoantigen vaccines – work, and why they could become a central player in the push to cure cancer.

Guest

Copyright 2021 NPR. To see more, visit https://www.npr.org.

You make NHPR possible.

NHPR is nonprofit and independent. We rely on readers like you to support the local, national, and international coverage on this website. Your support makes this news available to everyone.

Give today. A monthly donation of $5 makes a real difference.